Linzess Approval History
FDA Approved: Yes (First approved August 30, 2012)
Brand name: Linzess
Generic name: linaclotide
Dosage form: Capsules
Company: Allergan plc
Treatment for: Irritable Bowel Syndrome, Constipation, Chronic
Linzess (linaclotide) is a guanylate cyclase-C agonist indicated in adults for treatment of irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC).
Development History and FDA Approval Process for Linzess
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.